Dendritic cells (DCs) play a crucial role in the immune responses against infections by sensing microbial invasion through toll-like receptors (TLRs). In humans, two distinct DC subsets, CD11c− plasmacytoid DCs (PDCs) and CD11c+ myeloid DCs (MDCs), have been identified and can respond to different TLR ligands, depending on the differential expression of cognate TLRs. In this study, we have examined the effect of TLR-7 ligands on human DC subsets. Both subsets expressed TLR-7 and could respond to TLR-7 ligands, which enhanced the survival of the subsets and upregulated the surface expression of costimulatory molecules such as CD40, CD80, and CD86. However, the cytokine induction pattern was distinct in that PDCs and MDCs produced interferon (IFN)-α and interleukin (IL)-12, respectively. In response to TLR-7 ligands, the Th1 cell supporting ability of both DC subsets was enhanced, depending on the cytokines the respective subsets produced. This study demonstrates that TLR-7 exerts its biological effect in a DC subset-specific manner.
Skip Nav Destination
Article navigation
3 June 2002
Article Contents
Brief Definitive Report|
May 28 2002
Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets
Tomoki Ito,
Tomoki Ito
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Search for other works by this author on:
Ryuichi Amakawa,
Ryuichi Amakawa
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Search for other works by this author on:
Tsuneyasu Kaisho,
Tsuneyasu Kaisho
2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University
4RIKEN Research Center for Allergy and Immunology, Kanagawa 230-0045, Japan
Search for other works by this author on:
Hiroaki Hemmi,
Hiroaki Hemmi
2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University
3Solution-oriented Research for Science and Technology, Japan Science and Technology Corporation, Osaka 565-0871, Japan
Search for other works by this author on:
Kenichirou Tajima,
Kenichirou Tajima
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Search for other works by this author on:
Kazutaka Uehira,
Kazutaka Uehira
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Search for other works by this author on:
Yoshio Ozaki,
Yoshio Ozaki
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Search for other works by this author on:
Hideyuki Tomizawa,
Hideyuki Tomizawa
5Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama 335-8502, Japan
Search for other works by this author on:
Shizuo Akira,
Shizuo Akira
2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University
3Solution-oriented Research for Science and Technology, Japan Science and Technology Corporation, Osaka 565-0871, Japan
Search for other works by this author on:
Shirou Fukuhara
Shirou Fukuhara
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Search for other works by this author on:
Tomoki Ito
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Ryuichi Amakawa
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Tsuneyasu Kaisho
2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University
4RIKEN Research Center for Allergy and Immunology, Kanagawa 230-0045, Japan
Hiroaki Hemmi
2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University
3Solution-oriented Research for Science and Technology, Japan Science and Technology Corporation, Osaka 565-0871, Japan
Kenichirou Tajima
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Kazutaka Uehira
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Yoshio Ozaki
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Hideyuki Tomizawa
5Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama 335-8502, Japan
Shizuo Akira
2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University
3Solution-oriented Research for Science and Technology, Japan Science and Technology Corporation, Osaka 565-0871, Japan
Shirou Fukuhara
1First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
Address correspondence to Ryuichi Amakawa, First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570-8506, Japan. Phone: 81-6-6993-9453; Fax: 81-6-6994-8344; E-mail: [email protected]
Received:
February 07 2002
Revision Received:
April 02 2002
Accepted:
April 18 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (11): 1507–1512.
Article history
Received:
February 07 2002
Revision Received:
April 02 2002
Accepted:
April 18 2002
Citation
Tomoki Ito, Ryuichi Amakawa, Tsuneyasu Kaisho, Hiroaki Hemmi, Kenichirou Tajima, Kazutaka Uehira, Yoshio Ozaki, Hideyuki Tomizawa, Shizuo Akira, Shirou Fukuhara; Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets . J Exp Med 3 June 2002; 195 (11): 1507–1512. doi: https://doi.org/10.1084/jem.20020207
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement